STOCK TITAN

Progressive Care Gains SEC Reporting Status

Rhea-AI Impact
(High)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary

Progressive Care, Inc. (OTCQB: RXMD) announced the automatic effectiveness of its Registration Statement on Form 10 with the SEC, effective April 11, 2022. This move requires the company to file regular financial reports and comply with Exchange Act obligations, enhancing transparency and compliance for shareholders. CEO Alan Jay Weisberg emphasized the importance of being a fully reporting company for investor confidence and access to institutional capital. The company's commitment to corporate governance and plans for Nasdaq listing were also highlighted.

Positive
  • Automatic effectiveness of Form 10 enhances transparency for investors.
  • Compliance with SEC requirements may attract institutional capital.
  • Commitment to corporate governance supports long-term shareholder value.
Negative
  • None.

Progressive Care announced effective April 11, 2022, its Registration Statement on Form 10 filed with the U.S. Securities and Exchange

Miami, FL, April 12, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Progressive Care, Inc. (OTCQB: RXMD) (the “Company”), a personalized healthcare services and technology provider, today announced that, effective April 11, 2022, its Registration Statement on Form 10 filed with the U.S. Securities and Exchange (the “SEC”) to register its shares of common stock under Section 12(g) of the Securities Exchange Act of 1934 (the “Exchange Act”) became automatically effective.

The effective Form 10 obligates the Company to file Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, in addition to complying with all other obligations under the Exchange Act. In addition, management and certain shareholders are subject to the beneficial ownership reporting requirements of Section 13 and 16 of the Exchange Act.

Alan Jay Weisberg, Chairman and Chief Executive Officer of the Company, said, “For me, it was always important to have the Company become fully reporting with the SEC. I know how critical it is for individual and institutional investors to have the Company file its financial reports with the SEC as it provides a higher level of confidence in the information reported by the Company and a superior level of transparency. I believe that the Company’s compliance with the Exchange Act will ultimately help drive shareholder value and enable us to access higher quality institutional capital. We remain committed to strong corporate governance and steadfast in pursuit of our journey to Nasdaq.”

To view the Form 10 filling, please click:
https://www.sec.gov/Archives/edgar/data/0001402945/000149315222009357/form10-12ga.htm

Progressive Care, Inc.
Progressive Care, Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.

For more information about Progressive Care, please visit the company’s website.
Connect and stay in touch with us on social media:

Progressive Care Inc.
https://www.progressivecareus.com/ 
https://twitter.com/ProgressCareUS

PharmCoRx
https://www.pharmcorx.com/ 
https://twitter.com/PharmCoRx

ClearMetrX 
https://www.clearmetrx.com/ 
https://www.facebook.com/clearmetrx/

Forward-Looking Statements:
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.

Public Relations Contact:
Carlos Rangel
carlosr@pharmcorx.com

Investor Relations Contact:
ClearThink Capital
nyc@clearthink.capital
p917-658-7878


FAQ

What does the effective Form 10 mean for RXMD investors?

It requires Progressive Care to file regular financial reports, enhancing transparency and potentially increasing investor confidence.

When did the Form 10 for RXMD become effective?

The Form 10 became automatically effective on April 11, 2022.

How does the SEC compliance affect RXMD's stock?

SEC compliance may improve investor confidence and open access to higher quality institutional capital, potentially impacting the stock positively.

What are the future plans of Progressive Care after the Form 10 effectiveness?

The company aims for a Nasdaq listing, reflecting its commitment to growth and compliance.

PROGRESSIVE CARE INC

OTC:RXMD

RXMD Rankings

RXMD Latest News

RXMD Stock Data

13.49M
3.32M
48%
3.86%
Pharmaceutical Retailers
Healthcare
Link
United States of America
Hallandale Beach